Abstract Introduction Given the global increase in obesity prevalence, there has been an emergence of a multitude of treatment options, specifically less invasive operations, like intragastric balloons, and pharmaceutical treatments like semaglutide
Looking ahead, the next phase of obesity medicine will likely see GLP-1 medications used in combination with other weight loss agents, as well as expanded research into their effects on conditions like high blood pressure, heart attack risk, and liver disease
10 This is especially important as GLP-1 receptor agonists confer multiple benefits for patients with diabetes, including better glucose control and weight loss
What to verify semaglutide, tirzepatide, cash price and coverage terms, safety and contraindications How to use it Use this information to prepare sharper questions for a licensed provider
Mashayekhi M, Nian H, Mayfield D, Devin JK, Gamboa JL, Yu C, et al
For those using insurance, understanding the wegovy cost with insurance is crucial as it depends on your plan's specifics